日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits

肝脏单核多组分析揭示了心血管代谢特征的细胞类型机制

Alkhawaja, Abdalla A; Currin, Kevin W; Perrin, Hannah J; Vadlamudi, Swarooparani; Etheridge, Amy S; Broadaway, K Alaine; Cannon, Gabrielle H; Anderson, Carlton W; Moxley, Anne H; Iuga, Alina C; Schuetz, Erin G; Innocenti, Federico; Furey, Terrence S; Mohlke, Karen L

A mobile health app for real-time symptom monitoring in patients with cancer during COVID-19: feasibility, acceptability, and utility

一款用于在新冠肺炎期间实时监测癌症患者症状的移动健康应用程序:可行性、接受度和实用性

Shao, Ruosi; Neil, Jordan M; Chen, Meng; Hannafon, Bethany; Nipp, Ryan; Montgomery, Audrey; Frank-Pearce, Summer G; Moxley, Katherine; Richardson, Debra L; Elliott, Jacey; Benson, Lizbeth; Gossett, Amy Gin; Businelle, Michael S

Hydantion indolinones as AANAT inhibitors

作为 AANAT 抑制剂的乙二氢吲哚酮类

Wandrey, Nicole; Boley, Jake; Gómez-Galicia, Dirce; Hill, Mackinzi; Bach, Mason; Gawrych, Sidney; Hagemeister, Mackenzie; Cole, Philip A; Moxley, Michael A; Thomas, Allen A

The Benefits of a Digital Exercise Intervention for Older Adults: Findings From the Fittle Randomized Controlled Trial

数字运动干预对老年人的益处:Fittle随机对照试验的研究结果

Czaja, Sara J; Sharit, Joseph; Pirolli, Peter; Hernandez, Mario; Moxley, Jerad

Preparing for Practice: Evaluating a 3-Week Longitudinal Ward Simulation

实践准备:评估为期三周的纵向病房模拟

White, Philip; Amer, Jocelyn; Moxley, Adam

TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin

TBC1D30 调节胰岛素原和胰岛素分泌,并且是胰岛素原基因组关联信号的靶点。

Parsons, Victoria A; Vadlamudi, Swarooparani; Voos, Kayleigh M; Rohy, Abigail E; Moxley, Anne H; Cannon, Maren E; Rosen, Jonathan D; Mills, Christine A; Herring, Laura E; Broadaway, K Alaine; Lorenzo, Damaris N; Mohlke, Karen L

Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1.

利用有机核心高密度脂蛋白样纳米颗粒封装和递送激酶抑制剂PIK-75靶向清道夫受体B类1型

Rink Jonathan S, Lin Adam Y, Calvert Andrea E, Kwon David, Moxley Alexandra, Henrich Stephen E, Mohammadlou Aliakbar, Zhang Xu Hannah, Wu Xiwei, Querfeld Christiane, Griend Donald J Vander, Yin Hongwei Holly, Horne David A, Nguyen SonBinh T, Rosen Steven T, Gordon Leo I, Thaxton Colby Shad

Cancer vaccine trial evaluations: immunobridging and potential immunological endpoints

癌症疫苗试验评估:免疫桥接和潜在的免疫学终点

Hussain, Ahmed; Moxley-Wyles, Benjamin; Bryan, Michael; Gordon-Weeks, Alex; Al-Obaidi, Ibrahem; Sandhu, Ciaran; Lee, Lennard

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.

紫杉醇/卡铂+ Galunisertib(一种1型TGF-B受体激酶结构域的小分子抑制剂)治疗新诊断、持续性或复发性子宫或卵巢癌肉瘤患者的可行性IB试验。

Washington C, Dwivedi Shailendra Kumar Dhar, Gunderson-Jackson C, Walker J, Mannel R S, Holman L L, Richardson D L, Neelakantan D, Cohoon A, Ding K, Gatalica Z, Moxley K M, Landrum L M, Rowland M R, Bhattacharya R, Moore K N

Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer

Oklahoma nitrone-007 是一种有效的抗癌治疗药物,靶向子宫内膜癌中的炎症和免疫代谢通路。

Elayapillai, Sugantha Priya; Gandhi, Anjalika; Dogra, Samrita; Saunders, Debra; Smith, Nataliya; Hladik, Cole; Towner, Rheal A; Moxley, Katherine M; Hannafon, Bethany N